Safety and Tolerability of Recombinant Bet v 1 (rBet v 1) Tablets in Sublingual Immunotherapy (SLIT)

被引：14
|
作者：
Winther, L. [1 ]
Poulsen, L. K. [1 ]
Robin, B. [2 ]
Melac, M. [2 ]
Malling, H. [1 ]
机构：
[1] Natl Univ Hosp, Copenhagen, Denmark
[2] Stallergenes SA, Antony, France
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2009年 / 123卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2008.12.822
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
828
引用
收藏
页码：S215 / S215
页数：1
相关论文
共 50 条
  • [1] Safety and tolerability of recombinant Bet v 1 (rBet v 1) tablets in sublingual immunotherapy (SLIT)
    Winther, L.
    Poulsen, L.
    Robin, B.
    Melac, M.
    Malling, H.
    ALLERGY, 2009, 64 : 149 - 149
  • [2] Efficacy and safety of recombinant Bet v 1 (rBet v 1) tablets in sublingual immunotherapy
    Rak, S.
    De Blay, F.
    Worm, M.
    Robin, B.
    Melac, M.
    Malling, H.
    ALLERGY, 2010, 65 : 4 - 4
  • [3] ACTIVITY OF RECOMBINANT ALLERGEN - BET-V-1 (RBET-V-1) IN-VIVO
    GODNICCVAR, J
    BERGER, A
    SUSANI, M
    BREITENEDER, H
    STEINER, R
    HAVELEC, L
    RUDIGER, HW
    SCHEINER, O
    KRAFT, D
    CLINICAL AND EXPERIMENTAL ALLERGY, 1994, 24 (08): : 790 - 790
  • [4] Effects of subcutaneous specific immunotherapy with recombinant hypoallergenic Bet v 1 folding variant (rBet v 1-FV) on asthma symptoms
    Haefner, D.
    Tribanek, M.
    Kettner, J.
    Narkus, A.
    ALLERGY, 2013, 68 : 475 - 476
  • [5] Oral allergic syndrome and recombinant allergens rbet v 1 and rbet v 2
    Cadoni, S.
    Ruffelli, M.
    Fusari, S.
    de Pita, O.
    EUROPEAN JOURNAL OF INFLAMMATION, 2007, 5 (01) : 21 - 25
  • [6] IgE-cross-blocking antibodies to Fagales following sublingual immunotherapy with recombinant Bet v 1
    Grilo, Joao Rodrigues
    Kitzmueller, Claudia
    Aglas, Lorenz
    Sanchez Acosta, Gabriela
    Vollmann, Ute
    Ebner, Christof
    Horak, Fritz
    Kinaciyan, Tamar
    Radauer, Christian
    Ferreira, Fatima
    Jahn-Schmid, Beatrice
    Bohle, Barbara
    ALLERGY, 2021, 76 (08) : 2555 - 2564
  • [7] Antibody responses to sublingual treatment with recombinant bet v 1 and mal d 1
    Acosta, Sanchez G.
    Nagl, B.
    Kinaciyan, T.
    Bohle, B.
    ALLERGY, 2017, 72 : 725 - 725
  • [8] Safety and tolerability of grass pollen tablets in sublingual immunotherapy - a phase-1 study
    Larsen, T. H.
    Poulsen, L. K.
    Melac, M.
    Combebias, A.
    Andre, C.
    Malling, H. -J.
    ALLERGY, 2006, 61 (10) : 1173 - 1176
  • [9] Stability of rBet v 1-FV, a folding variant of rBet v 1
    Suck, R.
    Buenz, C.
    Braun, A.
    Schaeffer, B.
    Kischnick, S.
    Spangenberg, N.
    Kamionka, T.
    Cromwell, O.
    ALLERGY, 2008, 63 : 218 - 218
  • [10] IgE-blocking IGG1 antibodies to BET V 1-homologous food allergens following sublingual administration of RMAL D 1 and RBET V 1
    Demir, H.
    Strobl, M. R.
    Scheurer, S.
    Radauer, C.
    Kinaciyan, T.
    Bohle, B.
    ALLERGY, 2023, 78
12345